An apoptotic cellular defense mechanism is triggered in response to viral dsRNA generated during the course of infection by many DNA and RNA viruses. We demonstrate that apoptosis induced by dsRNA or a paramyxovirus is independent of the action of interferon as it can proceed in a variety of cell lines and primary cells deficient in an interferon response. Initiation of apoptosis appears to be triggered by activation of a cellular transcription factor, the dsRNAactivated factor (DRAF1). DRAF1 is composed of interferon regulatory factor 3 (IRF-3) and the transcriptional coactivators CREB binding protein (CBP) or p300. We find that activation of IRF-3 in the absence of viral infection stimulates apoptosis. In addition, a negative interfering mutant blocks both target gene induction and apoptosis, demonstrating a requirement for gene expression by IRF-3/DRAF1 to promote apoptosis. IRF-3/DRAF1 target gene expression is also induced in response to a distinct apoptotic stimulus, the DNA damaging agent etoposide. The activity of the p53 tumor suppressor does not appear to be required for IRF-3/DRAF1-mediated apoptosis.-Weaver, B. K., Ando, O., Kumar, K. P., Reich, N. C Apoptosis is promoted by the dsRNA-activated factor (DRAF1) during viral infection independent of the action of interferon or p53. FASEB J. 15, 501-514 (2001) 
The innate cellular response to viral infection involves activation of multiple signal transduction pathways within the infected cell. During the course of infection, many DNA and RNA viruses generate viral dsRNA by transcription or replication. This dsRNA is a potent stimulus of the defense response of the cell, stimulating signal pathways that lead to activation of transcription factors such as the nuclear factor kappa B (NFB) and the dsRNA-activated factor (DRAF1) (1) (2) (3) (4) . One set of genes induced in response to viral dsRNA is that encoding type I interferons (IFNs) (5, 6) . Newly synthesized IFNs are secreted from the cell and function to promote resistance to viral infection, control cellular proliferation, and activate cells of the immune system. IFNs bind to cell surface receptors and transmit a signal to the nucleus by activation of Janus tyrosine kinases ( JAKs) and a latent transcription factor, the IFN-stimulated gene factor 3 (ISGF3) (7) (8) (9) (10) . ISGF3 is composed of members of the signal transducer and activator of transcription factor (STAT) family, STAT1 and STAT2, and a member of the interferon regulatory factor (IRF) family, p48/IRF-9. ISGF3 binds to a DNA sequence, designated the IFN-stimulated response element (ISRE), in the promoters of responsive genes and induces the expression of IFN-stimulated genes (ISGs). The products of the ISGs mediate the biological effects of IFN.
The infected cell may gain little protective benefit from autocrine IFN due to the time required to produce and then respond to IFN. It is now clear that the infected cell induces a distinct subset of ISGs in direct response to virus infection or dsRNA, independent of IFN signaling (2, 3, 11) . We identified a specific cellular transcription factor activated in response to infection that binds to a DNA target site containing the ISRE and mediates gene induction. This factor was designated the dsRNA-activated factor, DRAF1 (2) (3) (4) . DRAF1 is now known to be a multimeric transcription factor composed of interferon regulatory factor 3 (IRF-3) and the transcriptional coactivators CREB binding protein (CBP) or p300 (4, (12) (13) (14) (15) . IRF-3 resides in the cytoplasm of uninfected cells, and after viral infection it accumulates in the nucleus in association with CBP or p300 to form DRAF1. Association with CBP or p300 is dependent on specific serine-threonine phosphorylation of IRF-3 by an activated protein kinase that remains to be identified.
IRF-3 is a member of a family of transcription factors known as IRFs (16 -18) . The IRF family is defined by their shared homology within an amino-terminal DNA binding domain. Through this DNA binding domain, IRF family members recognize a DNA sequence contained within an inner core of the ISRE. IRF-3 in complex with CBP/p300 as the DRAF1 transcription factor recognizes a DNA target site that includes the ISRE as well as several adjacent adenine residues (2, 3) . For this reason DRAF1 activates a distinct subset of genes induced by IFN.
Infection by many viruses and the biological effect of viral dsRNA signaling within a cell culminates in programmed cell death, or apoptosis (19, 20) . However, the mechanism whereby viral dsRNA triggers apoptosis is not completely understood. Apoptosis is a genetically programmed pathway of cell death that is mediated in two major execution programs initiated downstream of a death signal (21) (22) (23) . One of these programs is the caspase protease cascade; the other is mitochondrial dysfunction mediated by the BCL family of proteins. The decision to undergo apoptosis in many instances is regulated by the balance of proapoptotic proteins and antiapoptotic proteins present in the cell. In this report, we address whether activation of IRF-3/DRAF1 and subsequent induction of gene expression in response to viral dsRNA play a role in the promotion of apoptosis. The induction of apoptosis in virus-infected cells may serve to increase host survival by limiting the spread of infectious virions.
MATERIALS AND METHODS

Cell culture and reagents
HEC-1B, HeLa, and HT1080 cells were obtained from ATCC. U3A cells were a gift from George R. Stark MEFs were gifts from Paul J. Hertzog (Monash University, Australia) (25) . EB1 cells were a gift of Philip Shaw (CHUV Lausanne, Switzerland) (26) . Synthetic DNA and RNA polymers, poly (dI)-poly (dC), poly (I)-poly (C), poly(A), and poly C were purchased from Pharmacia Biotech (Piscataway, N.J.). Antibodies derived against IRF-3 were described (4). Antibodies to the HA epitope (F-7), FLAG epitope (OctAH6), CBP (A-22), p300 (N-15), and p53 (DO-1) were purchased from Santa Cruz Biotech, Inc. (Santa Cruz, Calif.). Antibody to the T7 epitope, was purchased from Novagen (Madison, Wis.). Antibody to CrmA (A71-1) and caspase 3 was purchased from PharMingen (San Diego, Calif.). Antibody to adenovirus 2 E1B 19 kDa protein (Ab-2) was purchased from Calbiochem (San Diego, Calif.). Polyclonal rabbit serum against PKR was a gift from Michael Mathews (New Jersey Medical School, UMDNJ, Newark). Etoposide was purchased from Clontech (Palo Alto, Calif.). Pfu DNA polymerase was purchased from Stratagene (San Diego, Calif.) and Taq DNA polymerase was purchased from Perkin-Elmer (Norwalk, Conn.).
Plasmid constructs
Human IRF-3 cDNA was cloned into pcDNA3 containing a T7 epitope tag (T7-IRF-3) at the amino terminus using a polymerase chain reaction (PCR). The cDNA encoding the constitutively active IRF-3 5D was a gift from John Hiscott (McGill University, Montreal, Canada) and was cloned into the pcDNA3-T7 vector (13) . The expression plasmid T7-⌬N60IRF-3 was constructed using PCR to amplify the IRF-3 region encoding 60 -427 aa. The plasmid, T7-DBDIRF-3, was constructed in a similar fashion and encodes the DNA binding domain of IRF-3 (1-118 aa). The plasmid expressing IRF-3 with the serine 396 to aspartic acid mutation was constructed using the Quick Change mutagenesis kit (Stratagene). The EGFP gene was purchased from Clontech. The green fluorescent protein (GFP)-IRF-3 construct was generated by PCR cloning EGFP upstream of IRF-3 (27) . PKR expression plasmid was a gift from Michael Katze (University of Washington, Seattle) (28). The CrmA cDNA was a gift from Yuri Lazebnik (Cold Spring Harbor Laboratory, N.Y.) and was subcloned into pcDNA3. Adenovirus E1B 19 K protein cDNA was a gift from Eileen White (Rutgers University, New Brunswick, N.J.) (29) was subcloned into pcDNA3.1(Ϫ). The expression plasmids encoding FLAG-tagged p53 mutant (F320 -393) and p53 were gifts from Ute Moll (SUNY Stony Brook, New York) (30) .
Transfections and infections
Cells were transfected with calcium phosphate-DNA coprecipitates with 15 g of total plasmid DNA per 60 mm plate, 7.5 to 30 g of dsRNA (poly I:poly (C), or ssRNA (poly(A) or poly C). A luciferase reporter gene assay was used containing a minimal promoter (31) with one copy of the ISG15 ISRE sequence (2) (3) (4) 32) . Luciferase activity was normalized to ␤-galactosidase activity by using the pSV-␤-Gal gene as a cotransfection control (Promega, Madison, Wis.). Newcastle disease virus (NDV) (NJ-LaSota-1946), a gift from Dr. Paula M. Pitha-Rowe (The Johns Hopkins University, Baltimore, Md.), was propagated in embryonated hen eggs and titers were determined by hemagglutination assay. Infections were performed at 100 hemagglutination units/ml or with allantoic fluid from mock-infected hen eggs (3).
Apoptosis assays
Nuclei were visualized after cell fixation in 4% formaldehyde, permeabilization with 0.5% Triton-X 100/phosphate-buffered saline (PBS), and DNA staining with 0.01 to 1.0 g/ml of 4Ј, 6-diamidino-2-phenylindole (DAPI) (Sigma, St. Louis, Mo.). The ApoAlert Annexin V-EGFP apoptosis detection kit was purchased from Clontech. Colorimetric protease assay kits for caspase activity were purchased from PanVera Corporation (Madison, Wis.). Assays were performed with substrates for caspase-8 (IETD-pNA) and caspase-3 (DEVD-pNA), and included controls with specific peptide inhibitors for caspase-8 (IETD-FMK) or caspase-3 (DEVD-FMK).
Immunoprecipitation and Immunoblot
Whole cell extracts were prepared by lysis in buffer containing 50 mM Tris (pH 7.6), 400 mM NaCl, 0.5% Nonidet P-40, 5 mM K-EDTA, 1 mM EGTA, 10 mM Naphosphate, 50 mM NaFl, and protease inhibitors. Immunoprecipitations were performed with excess antibody for 2-4 h at 4°C. Immunocomplexes were collected on protein-G agarose (GibcoBRL, Grand Island, N.Y.); proteins were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and electroblotted to Immobilon (Millipore). Immunoblotting with primary antibody was followed by secondary antibodies (Amersham) and enhanced chemiluminescence (DuPont NEN, Boston, Mass.).
Immunofluorescence
Cells were fixed in 4% formaldehyde and permeabilized in 0.5% Triton-X 100, blocked in 3% bovine serum albumin/ PBS-Tween-20 (0.1%), and incubated with either 0.1 g/ml of the T7 antibody, FLAG antibody, or control antibody in blocking solution. Secondary antibodies conjugated to Rhodamine were used ( Jackson ImmunoResearch Laboratories, Inc., West Grove, Pa.).
Protein-DNA binding assay
Electrophoretic mobility shift assays (EMSA) were performed as described with a DNA probe containing the ISG15 ISRE (2) (3) (4) 32) . Proteins were synthesized in vitro with a coupled transcription/translation system (Promega). 
Northern blot hybridization
RESULTS
Cells respond to viral infection with apoptosis independent of IFN action
Infection with different viruses elicits a cellular apoptotic response, and many viruses have evolved antiapoptotic strategies to block this response (34) . Apoptosis appears to play a role in native immunity, but the molecular signaling events by which cells react to virus and viral dsRNA remain unclear. We investigated whether the induction of gene expression by the dsRNA-activated transcription factor DRAF1 was involved in events leading to apoptosis. If DRAF1 plays a significant role in mediating the induction of apoptosis, apoptosis should proceed in the absence of IFN autocrine action. To address this, IFN-responsive cell lines (HeLa, HT1080) and IFN-unresponsive cell lines (U3A, HEC-1B) were tested for an apoptotic response to NDV. NDV and other members of the paramyxovirus family are known to evoke cellular apoptosis (35, 36) . U3A cells are deficient in STAT1 protein, and HEC-1B cells are defective in binding IFN (24, 37) . Therefore, both cell lines are defective in IFN signaling. Cells were either mock infected or infected with NDV and evaluated for morphological signs of apoptosis. Adherent cells were fixed and stained with the fluorescent DNA intercalating agent DAPI to visualize nuclear morphology. In all cases, NDV infection led to cell death characterized by several hallmarks of apoptosis, including morphological changes of rounding and refraction, loss of adherence, and development of pyknotic nuclei (i.e., nuclear condensation and fragmentation). The results indicate that cells respond to NDV with apoptosis either in the presence or absence of IFN signaling (Fig. 1A) . This IFN-independent apoptosis was not specific to immortalized cell lines as it was observed using primary murine embryo fibroblasts (MEFs) derived from either wild-type (wt) mice or mice deficient in the type I IFN receptor chain IFNAR1 (25, 38) . Both IFNAR1 ϩ/ϩ MEFs and o/o MEFs underwent cell death in response to NDV and showed apoptotic nuclear morphology (Fig. 1B) . Viral dsRNA is produced during infection, and treatment of cells with dsRNA in the absence of infection has been shown to induce apoptosis (39, 40) . However, other viral products can elicit apoptosis, such as the adenoviral E1A protein (41) . We addressed whether dsRNA, an activator of IRF-3/DRAF-1, was sufficient to induce apoptosis in the absence of IFN signaling. Transfection of cells with dsRNA, poly (I):poly (C), was found to induce apoptosis in wt MEFs and in IFNAR1-deficient MEFs as observed by nuclear morphology (Fig. 1B) . Apoptosis was not induced in mock-transfected cells or by transfection with single-stranded RNA, poly (A), or poly (C), or with dsDNA, poly (dI)-poly (dC) (data not shown). dsRNA-induced apoptosis was also observed in the human cell lines HeLa, HEC-1B, and U3A. Results of relative apoptosis induced by dsRNA in comparison to control ssRNA are displayed for HEC-1B and U3A cells (Fig. 1C) . These results indicate that apoptosis induced in response to virus infection and dsRNA can proceed in the absence of IFN action.
Apoptosis depicted by nuclear morphology was confirmed in a second manner. The annexin-V protein binds to phosphatidylserine (PS) and is used to detect PS translocation from the inner face of the plasma membrane to the outer surface during apoptosis. The annexin-V binding assay has been widely used as a measure for apoptosis (42) . HEC-1B cells and IFNAR1 o/o MEFs undergoing cell death in response to NDV infection were positive for annexin-V-EGFP binding (Fig. 1D) . Collectively, the results indicate that NDV or dsRNA directly induce apoptosis in both human and mouse cells, in both immortalized cell lines and primary cells, independent of IFN signaling.
Typically, apoptosis proceeds through a complex cascade of protease activation within the cell and subsequent proteolysis of cellular components (21, 22) . Since the proteases responsible for executing programmed cell death are the caspases, we examined whether caspases were activated during NDV-infection of IFN nonresponsive cells. The activity of caspase-8, an initiator caspase was first assessed. Lysates were prepared from cells either mock infected or infected with NDV, and caspase-8 activity was measured using a specific peptide substrate in a colorimetric protease assay ( Fig. 2A) . Caspase-8 was activated in both IFN responsive and unresponsive cells. A similar result was found for that of caspase-3 ( Fig. 2B ). Caspase-3 activation lies downstream of initiator caspases, and falls into a class referred to as the executioners. Activation of caspase-3 proceeds via cleavage of the 32 kDa proenzyme into 17 kDa and 12 kDa polypeptides that heterodimerize to form the active enzyme. The activation of caspase-3 by NDV infection was confirmed by detection of the 17 kDa cleaved subunit. HEC-1B, U3A, and HeLa cells were either mock infected, or infected for 20 h, or 40 h and proteins in cell lysates were analyzed by SDS-PAGE and subsequent immunoblotting (Fig. 2C ). NDV infection led to the appearance of the 17 kDa caspase-3 fragment and concomitant decrease in the level of the 32 kDa proenzyme form in all cell lines tested. We also tested the effect of broad-spectrum caspase inhibitor, z-VAD-FMK, on the appearance of cellular apoptosis during NDV infection (36, 43) . Inclusion of z-VAD-FMK during NDV infection completely blocked the increased incidence of pyknotic nuclei, although a delayed cytopathic effect was still apparent (data not shown). Taken together, these results confirm that NDV infection induces apoptosis in a caspase-dependent and IFN-independent manner.
Activation of IRF-3/DRAF1 promotes apoptosis
Since viral dsRNA appears to promote apoptosis and to activate IRF-3/DRAF1, a direct role of IRF-3/DRAF1 in the apoptotic response was further investigated. The effects of expression plasmids encoding IRF-3 or mutant forms of IRF-3 were tested (Fig. 3A) . To demonstrate intrinsic DNA binding properties, an in vitro transcription/translation system was used to generate wt or mutant forms of IRF-3. The in vitro translated products were analyzed by an EMSA with a radiolabeled ISRE probe (Fig. 3B) . Prior to infection, wild-type IRF-3 in its unmodified form lacks intrinsic DNA binding ability (4) . It was reported previously that a constitutively active mutant of IRF-3 could be produced by substitution of five carboxyl serine or threonine residues with the phosphomimetic aspartic acid (IRF-3 5D) (13) . In vivo, this mutation promotes IRF-3 association with CBP or p300 in the nucleus in the absence of viral infection and induces gene transcription. In vitro, the constitutively active IRF-3 5D protein can bind the ISRE target site. The modification appears to alter protein conformation and promote DNA binding. A T7 epitope tag positioned upstream of the DNA binding domain (T7-IRF-3 5D) does not impair its ability to function. A single serine 396 to aspartic acid mutation within the IRF-3 carboxyl terminus is not sufficient to allow the protein to bind DNA. A truncated protein encoding just the amino-terminal DNA binding domain of IRF-3, T7-DBDIRF-3, is competent to bind the ISRE. The T7-DBDIRF-3 protein contains the nuclear localization signal of IRF-3 and localizes to the nucleus in vivo constitutively (12, 27 ). An amino-terminal deletion mutation in IRF-3, T7-⌬N60IRF-3, lacks a portion of the DNA binding domain and cannot recognize DNA. However, in vivo this protein can be phosphorylated in response to viral infection and accumulate in the nucleus in association with CBP/p300 (12, data not shown).
Expression plasmids encoding T7-IRF-3, T7-IRF-3 5D, T7-DBDIRF-3, or T7-⌬N60IRF-3, were transfected o/o MEFs, U3A, and HeLa cells were either mock infected or infected with NDV. Cells were collected and lysates were prepared. Caspase-8 protease activity was measured with a specific peptide substrate in a colorimetric assay measured in a microtiter plate reader at 405 nm. The values from mock-infected cultures were set as 1 to determine the relative increase in caspase activity after infection. B) Activation of caspase-3 in response to NDV infection. Cells were treated and cell lysates were prepared as described in panel A with a specific peptide substrate. C) Caspase 3 cleavage/activation during NDV infection. HEC-1B, U3A, and HeLa cells were either mock infected (m) (lanes 1, 4, and 7) or infected with NDV for 20 h (lanes 2, 5, and 8) or 40 h (lanes 3, 6, and 9). Cell lysates were prepared and subjected to SDS-PAGE and immunoblot (IB) with a polyclonal rabbit antiserum against caspase-3. The antiserum detects the proenzyme form of 32 kDa and the activated form subunit of 17 kDa.
into IFN unresponsive HEC-1B cells to evaluate their effect. At 48 h post-transfection, adherent cells were fixed and stained with DAPI to detect nuclear morphology and coordinate expression of IRF-3 was detected by immunofluorescence with T7 antibodies. The percent apoptosis in the culture was quantified -3) , an expression plasmid for T7-IRF-3 (lanes 4 -5), or expression plasmid for T7-IRF-3 5D (lanes 7-9). At 24 h post-transfection, cell lysates were subjected to immunoprecipitation with either a control (c) rabbit antibody (lanes 1, 4, and 7), rabbit antibody to IRF-3 (lanes 2, 5, and 8), or a mixture of polyclonal antibodies to CBP and p300 (lanes 3, 6, and 9). Immunoprecipitated proteins were separated by SDS-PAGE and detected by immunoblot (IB) with a mAb against the T7 tag (␣T7) to visualize the transfected proteins (upper panel) and subsequently with a murine polyclonal antibody to IRF-3 (␣IRF-3) (lower panel).
by the number of cells positive for the T7 epitope that had pyknotic nuclei detected with DAPI (Fig.  3C) . Expression of T7-⌬N60IRF-3 or T7-DBDIRF-3 elicited low apoptotic indices similar to a vector control. However, in response to T7-IRF-3 5D, ϳ45% of the cells demonstrated apoptotic nuclei, and expression of the wt T7-IRF-3 protein demonstrated approximately ϳ35% apoptosis. This latter result with wt T7-IRF-3 was unexpected since, in uninfected cells, IRF-3 exists in a latent inactive state in the cytoplasm of the cell (4, (12) (13) (14) (15) . It implied that wt T7-IRF-3 was activated during the transient expression assay. To investigate whether the transfected T7-IRF-3 protein was activated, a coimmunoprecipitation assay was performed to determine whether it associated with CBP/p300 (Fig. 3D) . HEC-1B cells were transiently transfected with vector, T7-IRF-3, or T7-IRF-3 5D expression plasmids and proteins were immunoprecipitated from lysates with control antibody, IRF-3 antibody, or a mixture of CBP and p300 antibodies. Transfected IRF-3 proteins were detected by immunoblot with a T7 antibody (upper panel) or an IRF-3 antibody to detect both the endogenous IRF-3 and transfected proteins (lower panel). The results demonstrated that transient transfection of IRF-3 resulted in activation of a portion of the expressed protein as measured by its association with CBP/p300. The proportion of wt T7-IRF-3 protein that associated with CBP/p300 was considerably less than that of the active IRF-3 5D protein, but the level appears sufficient to induce cellular apoptosis. The increase in apoptosis by IRF-3 or IRF-3 5D overexpression was also observed in the U3A cell line (data not shown).
To ensure that the cell death mediated by T7-IRF-3 5D was indeed due to apoptosis, the effects of the characterized apoptosis inhibitors adenovirus E1B 19K and cowpox virus protein CrmA were examined in cotransfection assays. The E1B 19K protein is a viral homologue of the BCL-2 family of antiapoptotic proteins and has been shown to inhibit apoptosis induced during adenovirus infection and by several other apoptotic stimuli (41, 44) . CrmA is a cowpox viral protein that binds to and inhibits members of the caspase family of proteases, and thus inhibits apoptosis induced by a variety of agents (45) . HEC-1B cells were cotransfected with an expression plasmid encoding GFP and either control vector or expression plasmids encoding T7-IRF-3 5D alone or with E1B 19K or CrmA. Cells expressing GFP were identified by fluorescent microscopy and used as a cotransfection indicator. At 48 h post-transfection, the percent apoptosis in the culture was quantified by the number of cells positive for GFP fluorescence that had pyknotic nuclei detected with DAPI staining (Fig. 4) . Using GFP as a cotransfection indicator generated a slightly lower apoptotic index, but best represented the effects of coexpression of different untagged plasmids. Coexpression of either E1B 19K or CrmA was able to inhibit the incidence of pyknotic nuclei and apoptotic cell death mediated by T7-IRF-3 5D expression. Protein expression of E1B 19K and CrmA was confirmed by immunoblot (data not shown). This inhibitory effect of E1B 19K and CrmA was not due to a nonspecific inhibition of T7-IRF-3 5D expression (Fig. 4, lower panel) . As a positive control, the effect of a characterized proapoptotic protein, the dsRNA-activated protein kinase (PKR), was also evaluated in this cotransfection assay (Fig. 4) (19, 46 ). PKR showed a similar level of apoptosis induction quantified by pyknotic nuclei in cells coexpressing GFP.
Activation of gene expression by IRF-3/DRAF1 is requisite for apoptosis
Since a fraction of wt IRF-3 was activated during transient transfection to form DRAF1, it should elicit a specific effect on gene transcription. This was confirmed by cotransfection of IRF-3 with an ISRE-lucif- erase reporter gene assay (Fig. 5A) . HEC-1B cells were cotransfected with the reporter gene and vector alone, T7-DBDIRF-3, or T7-IRF-3. Transfection of IRF-3 resulted in approximately a fourfold increase in specific gene expression. Since IRF-3 activation appears to promote apoptosis, a logical hypothesis for the mechanism by which this occurs is via the activation of IRF-3 target genes. To test this hypothesis, a negative interference approach was used to inhibit IRF-3-mediated gene expression. The DBDIRF-3 protein containing only 1-118 aa binds the ISRE target site, but not CBP/p300 and has been shown to constitutively localize to the nucleus in vivo (Fig. 3) (12, 27) . Through competitive binding to DNA, DBDIRF-3 should act as a dominant negative interfering mutant of IRF-3. Coexpression of T7-DBDIRF-3 with T7-IRF-3 was found to inhibit IRF-3-mediated activation of the ISRE reporter gene in a dose-dependent manner (Fig. 5A) . The repressive effect of T7-DBDIRF-3 was not due to a nonspecific repression in the level of T7-IRF-3 protein (lower panel).
To determine whether IRF-3-mediated apoptosis was dependent on activation of target gene expression, T7-IRF-3 was cotransfected with a negative interfering mutant, T7-DBDIRF-3, and an apoptosis assay was performed (Fig. 5B) . A GFP expression plasmid was used as a marker for the cotransfection. Cells were fixed and stained with DAPI to visualize nuclear morphology. The expression of T7-IRF-3 elicited a threefold increase in apoptotic cells, and this increase in apoptosis was completely inhibited by the coexpression of T7-DB-DIRF-3. As positive controls for the inhibition of apoptosis, IRF-3 was coexpressed with the apoptosis inhibitors E1B19K or CrmA. The results indicate that IRF-3-mediated apoptosis is dependent on the transcriptional activation of target genes containing the ISRE.
The effect of a dominant interfering mutant of IRF-3 was also tested during the cellular response to NDV infection. ISRE-mediated gene expression is induced during viral infection of HEC-1B cells (2, 3) . To test the effect of an IRF-3 interfering mutant, cells were transfected with the ISRE-luciferase reporter gene and vec- tor plasmid or plasmids encoding T7-DBDIRF-3 or T7-⌬N60IRF-3, and subsequently mock-infected or infected with NDV (Fig. 6A) . NDV infection led to ϳ20-fold induction of the reporter gene, whereas coexpression of T7-DBDIRF-3 or T7-⌬N60IRF-3 dramatically inhibited ISRE-mediated gene expression. Although T7-⌬N60IRF-3 cannot bind DNA, it may inhibit IRF-3 by sequestration of CBP/p300 (4, 12, 13, 27) .
To address whether gene induction mediated by IRF-3/DRAF1 is necessary for apoptosis in response to NDV infection, a similar transient transfection-apoptosis assay was performed in combination with virus infection (Fig. 6B) . HEC-1B cells were cotransfected with expression plasmids for GFP and either empty vector, T7-IRF-3, T7-DBDIRF-3, E1B 19K, or CrmA. Subsequently cells were either mock-infected or infected with NDV, and the adherent cells were fixed and stained with DAPI to visualize nuclear morphology. The percent of apoptosis was expressed as GFP-positive cells with pyknotic nuclei. Cells with vector alone responded to NDV infection with ϳ35% apoptosis. Cotransfection of IRF-3 did not significantly enhance the apoptosis, indicating a surplus of endogenous IRF-3 protein.
Expression of either of the antiapoptotic proteins E1B 19K or CrmA inhibited the level of NDV-induced apoptosis. More significantly, expression of the negative interfering IRF-3 mutant T7-DBDIRF-3 inhibited cellular apoptosis in response to viral infection. Expression of T7-DBDIRF-3, E1B19K, or CrmA inhibited the appearance of pyknotic nuclei in response to NDV infection, but did not completely inhibit the cytopathic effect of the virus. These results demonstrate that expression of cellular target genes by IRF-3/DRAF1 is required for apoptosis in response to viral infection.
Effect of etoposide and p53 on IRF-3/DRAF1 induced apoptosis
It is clear that the induction of gene expression by IRF-3/DRAF1 in response to viral dsRNA is critical in mediating a cellular apoptotic response, but only a few genes are known to be induced directly by IRF-3/ DRAF1. One of these genes, ISG54, can clearly be shown to be induced by either dsRNA or by the activation of IRF-3 in cells unresponsive to autocrine IFN (3, 11, 33) (Fig. 7A) . To follow expression of the endogenous ISG54 gene, cells were transfected with either dsRNA as poly (I):poly (C) or with the gene encoding the constitutively active IRF-3 5D. Northern blot analysis readily detects expression of endogenous ISG54 mRNA in response to dsRNA or IRF-3 5D.
To investigate a possible involvement of IRF-3/ DRAF1 in the cellular response to DNA-damaging agents that induce apoptosis, the effect of etoposide on expression of the ISG54 gene was assessed. The plant derivative etoposide is a cancer therapy drug used to induce apoptosis. Etoposide inhibits the DNA unwinding enzyme topoisomerase II, and this leads to an increase in DNA strand breaks and protein levels of the p53 tumor suppressor (47) (48) (49) . U3A cells or HT1080 cells were untreated, treated with etoposide, or infected with NDV. RNA was prepared and analyzed by Northern blot hybridization to detect ISG54 mRNA or GAPDH mRNA as a control. The ISG54 gene was found to be induced in response to either NDV or etoposide (Fig. 7B) . A reduction in GAPDH mRNA was observed during viral infection that may indicate the activation of a latent RNase, and for this reason the ISG54 induction may be underestimated (50) . Induction of ISG54 in response to virus or etoposide is independent of autocrine IFN action since U3A cells lack STAT1 and cannot respond to IFNs. To determine whether IRF-3/ DRAF1 could be responsible for gene induction in response to etoposide, activation of IRF-3 was evaluated. Activated IRF-3 is known to relocalize from the cytoplasm to the nucleus in response to dsRNA or viral infection (4, (12) (13) (14) (15) 27) . To detect IRF-3/DRAF1 activation, cells were transfected with GFP-IRF-3 expressing a GFP-IRF-3 fusion protein (27) . Cells were either untreated or treated with etoposide, and GFP-IRF-3 protein was visualized by fluorescence microscopy (Fig.  7C) . The results indicated that IRF-3 was activated in response to the apoptotic agent etoposide since GFP-IRF-3 accumulated in the nucleus.
Etoposide leads to activation of the p53 tumor suppressor, and p53 activation is known to be able to trigger apoptosis (47, 49, (51) (52) (53) (54) (55) . For this reason, the involvement of p53 was investigated in the IRF-3-mediated cellular response. It was first necessary to demonstrate that the IFN-unresponsive cells were sensitive to the apoptotic effects of p53. This was demonstrated by overexpression of p53 in HEC-1B cells (Fig. 8A) . To control for the involvement of p53, a dominant negative approach was used with a p53 mutant encoding a carboxyl-terminal domain of p53 (F320 -393) (30) . This truncated form of p53 forms nonfunctional hetero-oligomers with endogenous p53 and blocks p53 dependent action (56, 57) . Cells were transfected with plasmids expressing GFP with p53 or dominant negative (DN) p53, or with both p53 and DNp53. Cells were evaluated for GFP expression and apoptotic nuclei with DAPI staining. p53 overexpression clearly induced apoptosis in the HEC-1B cultures, and coexpression of DNp53 inhibited the apoptosis.
To evaluate the effect of increased p53 levels and concomitant apoptosis in the absence of DNA damage or a transfection, a cell line that expresses wt p53 under the control of the metallothionein promoter was used (55) . If p53 indirectly or directly stimulates IRF-3/ DRAF1 activity, DRAF1 target genes should be induced. Cells were treated with zinc sulfate to induce high levels of p53 synthesis, and expression of endogenous ISG54 mRNA was measured. A Northern blot of RNA isolated from untreated or treated cells did not reveal induction of ISG54, although p53 protein levels increased (Fig.  8B, C) . This result suggests that p53-mediated apoptosis does not require IRF-3/DRAF1, whereas the effects of etoposide stimulate signals to activate both p53 and IRF-3/DRAF1 and thereby induce ISG54 mRNA expression.
Although p53-mediated apoptosis did not appear to require the action of IRF-3/DRAF1, it remained possible that IRF-3/DRAF1-mediated apoptosis required the action of p53. To determine the involvement of p53, a dominant negative approach was used with the p53 mutant encoding the carboxyl-terminal domain of p53 (30) . Cells were transfected with plasmids expressing GFP and the active IRF-3 5D in the absence or presence of cotransfected DNp53 and evaluated for apoptotic nuclei with DAPI staining. Expression of p53 was detected by immunofluorescence with antibodies to a FLAG epitope tag. Apoptosis induced by IRF-3 5D was found to be unaffected by DNp53 since there was no alteration in the apoptosis induced in the absence or presence of cotransfected DNp53 (Fig. 8D) . The results suggest that apoptosis mediated by IRF-3/DRAF1 is independent of the action of p53.
DISCUSSION
Cells respond to the presence of viral dsRNA produced during the course of infection with activation of latent transcription factors and the induction of genes critical to viral defense. One set of induced genes encodes the type I IFN cytokines that function as paracrine media- tors of the native immune response (5, 6) . IFNs are secreted, bind to cell surface receptors, and elicit biological changes that confer resistance to viral infection. It is also clear that the infected cell has an intrinsic response mechanism that results in apoptosis. Therefore, a delicate temporal balance must exist of antiapoptotic signals to allow production and secretion of protective cytokines and proapoptotic signals to initiate cell suicide.
We demonstrate in this report that NDV infection and viral dsRNA stimulate apoptosis in the absence of IFN action since it occurs in cells that cannot respond to IFN. Apoptosis was measured by the development of pyknotic nuclei, phosphatidyl serine externalization, and activation of caspase proteases. An earlier report suggested that the apoptotic response to virus was dependent on the action of IFNs, although IFN treatment by itself was not sufficient to induce apoptosis (58) . Although it remains to be determined how different viruses or other factors influence cellular apoptosis, our results strongly suggest that this response is activated independent of the IFN pathway.
Since we earlier identified DRAF1 as a transcription factor that is activated in response to viral infection or dsRNA transfection, we hypothesized that DRAF1 could be a mediator of cellular apoptosis (2-4). The IRF-3 component of DRAF1 is phosphorylated during viral infection, and this modification allows IRF-3 to bind to CBP or p300 and accumulate in the nucleus as DRAF1 (4, (12) (13) (14) (15) 27) . To investigate the possibility that DRAF1 induces transcription of genes that initiate apoptosis, we tested the effect of overexpression of wtIRF-3 and mutations of IRF-3 in the absence of viral infection in cells that lack a response to IFN.
Transient overexpression of IRF-3 or a constitutively active mutant, IRF-3 5D, led to an enhancement of apoptosis during a transient transfection. Apoptosis was measured by the appearance of pyknotic nuclei at a specific time and therefore does not include cells that have lifted from the surface or have not yet progressed to terminal stages of apoptosis. Even within this window of time, a significant level of apoptosis was visible in the cultures expressing IRF-3 5D, and was also apparent with wt IRF-3 (Fig. 3 ). It appears that introduction of plasmid DNA can lead to activation of signaling pathways sensitive to dsRNA and the phosphorylation and activation of wt IRF-3. Apoptosis induced by activated IRF-3 or by NDV infection can be inhibited by the well-characterized antiapoptotic proteins adenovirus E1B 19K and cowpox CrmA. More significantly, the apoptotic response can be inhibited by coexpression of a mutant of IRF-3 that blocks specific gene transcription by DRAF1. The dominant negative DNA binding domain (DBDIRF-3) localizes to the nucleus and appears to occupy target sites without the ability to activate gene expression (12, 27) .
The p53 tumor suppressor occupies a prominent role in the apoptotic response of the cell to stress signals such as oncoproteins, hypoxia, and DNA damage (51) (52) (53) (54) (55) . To determine the involvement of p53 in the apoptotic response to viral infection and IRF-3/ DRAF1 activation, we first evaluated a genotoxic stress inducer, etoposide, and the induction of high levels of p53. Genotoxic stress inducers have recently been reported to activate IRF-3, which can be demonstrated by visualizing the localization of a GFP-IRF-3 fusion protein with fluorescent microscopy (Fig. 7) (59) . The induction of apoptosis by etoposide was found to result in the activation of IRF-3/DRAF1 and specific expression of an endogenous responsive gene ISG54. Etoposide can therefore elicit stress signals that lead to the induction/activation of p53 and to the activation of IRF-3/DRAF1. p53 induction in the absence of other stress inducers did not result in ISG54 gene expression, indicating that p53 does not activate IRF-3/DRAF1 or the set of genes known to be responsive to IRF-3/ DRAF1. In addition, a dominant negative p53 mutant did not alter apoptosis induced by IRF-3/DRAF1, indicating independence of the action of p53.
Two other IRF transcription factors have been demonstrated to play a role in promoting apoptosis by different agents (60 -62) . IRF-1 has been implicated in oncogene-induced apoptosis and DNA damage-induced apoptosis in mature lymphocytes. However IRF-1 activation was not sufficient to induce apoptosis on its own. IRF-8, also known as interferon consensus sequence binding protein (ICSBP), appears to be involved in apoptosis since myeloid cells from mice deficient in IRF-8/ICSBP show a decrease in both spontaneous apoptosis during development and in that induced by DNA damage. Our study presents evidence for a mechanism by which viral dsRNA leads to apoptosis of infected cells with the activation of the IRF-3/ DRAF1 transcription factor. The study clearly indicates that apoptosis in response to dsRNA or NDV infection is independent of the action of IFN as it occurs in various cells deficient in the IFN signal pathway.
This report presents evidence demonstrating that apoptosis induced in response to the paramyxovirus, NDV, or dsRNA proceeds independent of interferon or p53 action. Activation of the IRF-3/DRAF1 transcription factor by dsRNA leads to the induction of a subset of cellular genes whose products stimulate apoptosis. This apoptotic response to viral infection has apparently evolved as a mechanism to limit the dissemination of virus.
